Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 2221  |  »Ø¸´: 41
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û25´Î£¬×÷Õßluai071Ôö¼Ó½ð±Ò 18.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] µÚÈý½ì¹ú¼ÊÀíÂÛ»¯Ñ§¡¢·Ö×ÓÄ£ÄâºÍÉúÃü¿ÆÑ§ÑÐÌÖ»áÂÛÎļ¯--»¯Ñ§¼°·Ö×ÓÄ£Äⲿ·Ö

µÚÈý½ì¹ú¼ÊÀíÂÛ»¯Ñ§¡¢·Ö×ÓÄ£ÄâºÍÉúÃü¿ÆÑ§ÑÐÌÖ»áôßµÚÈý½ì±±¾©ºê½£¹«Ë¾Óû§´ó»áÂÛÎº

Ö÷½²µÄѧÕß¶¼ÊÇÒµÄڵľ«Ó¢£¬ÄÚÈÝÊ®·Ö¾«²Ê¡£²»¶à˵ÁË£¬´ó¼ÒÏÂÔØ°É¡£¶ÔÁË£¬±ðÍü¸øÔÚÏÂÒ»µã¹ÄÀø£¬Ð»Ð»£¡

Óгæ×Ó˵Ãû×ÖºÍÄÚÈݲ»·û£¬ÆäʵÕâ´Î´ó»áÉϵĻ¯Ñ§ºÍ·Ö×ÓÄ£Äⲿ·Ö¶¼ºÍÉúÃüÉúÃü¿ÆÑ§Óйأ¬¶øÇÒ±¾½ì´ó»áµÄÖ÷°ìµ¥Î»Ö®Ò»£ººê½£¹«Ë¾¾ÍÊÇ´úÀíÍâ¹úµÄÒ©ÎïÉè¼ÆÈí¼þµÄ£»´ËÍâÎÒÕâÀﻹÓвÄÁÏ¿ÆÑ§²¿·Ö£¬ÒѾ­·¢µ½²ÄÁϰæÁË¡£

[ Last edited by luai071 on 2007-11-1 at 12:15 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

moonway111

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

http://gx001d.mofile.com/0644639 ... A../Papers--Bio.pdf
ÓÃÕâ¸öµØÖ·¿ÉÒÔÖ±½ÓÁË~
24Â¥2007-11-01 13:30:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 42 ¸ö»Ø´ð

luai071

ľ³æ (ÖøÃûдÊÖ)


ÉúÃü¿ÆÑ§Æª
Theoretical Study of the Vertical Excited States of Benzene, Pyrimidine, and Pyrazine by the Symmetry A
dapted Cluster¡ªConfiguration Interaction Method¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­...P311
Molecular Docking and Three-Dimensional Quantitative Structure-Activity Relationship Studies on the
Binding Modes of Herbicidal 1-(Substituted Phenoxyacetoxy)alkylphosphonates to the E1 Component of
Pyruvate Dehydrogenase¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­P321
A Time-Dependent Density Functional Theory Investigation of the Spectroscopic Properties of the ¦Â -Subunit
In C-Phycocyanin¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­.P331
Structures and properties of cytosine¨CBX3 (XZF, Cl) complexes: an investigation with DFT and MP2 methods
¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P336
Similarity Networks of Protein Binding Sites¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P346
Empirical Correction to Molecular Interaction Energies in Density Functional Theory (DFT) for Methane
Hydrate Simulation¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P355
Potential of Eigen Value Method to the Study on Structure-antioxidant Activity Relationship¡­¡­¡­¡­¡­¡­¡­..P363
CoMFA 3D-QSAR Analysis of Epothilones Based on Docking Conformation and Alignment¡­¡­¡­¡­¡­¡­¡­.P370
HIV µ°°×øÒÖÖÆ¼Á¡ª¡ªÀûµÏÁ´¾úËØµÄ·Ö×Ó¶Ô½ÓÑо¿¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...P378
3D-QSAR studies on glycogen phosphorylase inhibitors by flexible comparative molecular field analysis..........P383
µÚ 3 Ò³
Complex-type-dependent scoring functions in protein¨Cprotein docking¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­P389
High-throughput real-time assay based on molecular beacons for HIV-1 integrase 3'-processing reaction............P400
Prediction of the binding mode between BMS-378806 and HIV-1 gp120 by docking and molecular dynamics
simulation¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P407
Analysis of Domain Movements in Glutamine-Binding Protein with Simple Models¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­P414
Peptide Reagent Design Based on Physical and Chemical Properties of Amino Acid Residues¡­¡­¡­¡­¡­¡­¡­.P424
Multiple Field Three Dimensional Quantitative Structure¨CActivity Relationship (MF-3D-QSAR)¡­¡­¡­¡­¡­..P432
Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of
neuraminidases¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P443
Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino
acid-based peptide prediction¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...P450
Prediction of Distribution of Neutral, Acidic and Basic Structurally Diverse Compounds Between Blood and
Brain by the Nonlinear Methodology¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P457
Theoretical studies on the formation of N-nitrosodimethylamine¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­P485
Conformers and Properties of Proline¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...P491
3D-QSAR studies on tripeptide aldehyde inhibitors of proteasome using CoMFA and CoMSIA methods¡­¡­¡­P498
Quantum and Molecular Dynamics Study for Binding of Macrocyclic Inhibitors to Human a-Thrombin.¡­¡­¡­P512
Evaluation of FlexX, GOLD and LigandFit on Their Docking Performance Using a Diverse Test Set Derived
from the PDBbind Database¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.................P513
Physics-based Scoring Method in Drug Discovery¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..........P515
ϸ°ûÄÚ¸ÆÀë×ÓÕñµ´ÌåϵÖеÄËæ»úЧӦ¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P517
µ°°×ÖÊ´¿»¯·ÂÉúÇ׺ÍÅäÌåÑо¿¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...¡­...P519
ǿְ©ÐÔN-ÑÇÏõ°·ÐγɻúÀí¼°¹ýÑõÑÇÏõËá¸ù¶¾ÐÔ»úÀíµÄÑо¿¡­...¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P520
ÖйúÉúÎï¼¼ÊõÖÆÒ©ÓëÅ·ÃÀ¹ú¼ÒµÄ±È½Ï. ¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..¡­¡­¡­¡­..P521
Comparison of Biophamaseutics among USA, EU and China¡­¡­¡­¡­...¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.P526
Study on QSSR with the atomic ionicity indices¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­..¡­¡­¡­..P527
Study of molecular docking of mu opioid receptor agonist---fentanyl and its analogs based on Surflex-Docking
¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P537
Mu °¢Æ¬ÊÜÌåµÄÈýά½á¹¹Ä£½¨¼°»îÐÔλµã·ÖÎö¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..........P547
ÒÔG-ËÄÁ´ÌåΪ°Ð±êµÄ¿¹Ö×ÁöÒ©ÎïÐéÄâɸѡ¡¢·Ö×Ó»úÀí¼°ÉúÎï»îÐÔÑо¿¡­¡­¡­¡­...¡­¡­¡­¡­..¡­¡­¡­¡­...P552
Studies on virtual screening, molecular mechanism and bioactivity of anti-cancer drug targeting G-quadruplex
¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...¡­¡­¡­¡­¡­¡­¡­...P553
»ùÓÚDNA °Ð·Ö×Óʶ±ðµÄ¿¹Ö×ÁöÒ©ÎïµÄÉè¼Æ¡¢·Ö×Ó»úÀí¼°ÉúÎï»îÐÔÑо¿¡­¡­¡­¡­¡­¡­¡­¡­...¡­¡­¡­¡­...P554
Comparative Evaluation of 15 Scoring Functions on PDBbind Core Set of 210 Protein-Ligand Complexes¡­¡­P555
Evaluation of MM/PBSA method on NMR structures¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..¡­¡­¡­¡­¡­..P557
Pharmacophore screening with piperdinecarboxamides derivatives using GALAHAD study and CoMFA study
based on these pharmacophores¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...........P559
ÐÂÑ̼îÀàɱ³æ¼Á¼°Ïà¹Ø»¯ºÏÎï½á¹¹Óë»îÐÔ¹ØÏµµÄCoMFA ¼°CoMSIA Ñо¿¡­¡­¡­¡­¡­¡­¡­¡­¡­............P571
Ò©ÎïÐéÄâɸѡµÄ³É¹¦Óë²»×ã¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..............P583
Design, Synthesis and Preliminary Activity Assay in vitro of L-lysine Derivatives as APN Inhibitors¡­¡­¡­¡­.P584
A molecular dynamics and QM/MM study on the acetylating inactivation of isoniazid¡­¡­¡­¡­¡­¡­.¡­...........P585
Conformation-Based Design of Camptothecin Analogues as Potent DNA Topoisomerase I inhibitors¡­............P586
Multiscale modelling and simulation of biological systems¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­............P587
Models for binding cooperativities of inhibitors with transthyretin¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­............P589
Three-dimensional common-feature hypotheses for fentanyl derivatives¡­¡­¡­¡­...¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­...P602
µÚ 4 Ò³
2Â¥2007-10-30 16:52:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)


´óС ÎļþÃû
21.7M  Papers--Bio.pdf

  
ÒѾ­³É¹¦µØ±£´æÔÚMofile  
ÎļþÌáÈ¡Â룺 0644639448462145
  
    µ±ÄúµÄÅóÓÑÐèÒªÌáÈ¡´ËÎļþʱֻÐè:
     ÄäÃûÌáÈ¡ÎļþÁ¬½Ó http://pickup.mofile.com/0644639448462145  
     »òµÇ¼Mofile£¬Ê¹ÓÃÌáÈ¡Âë 0644639448462145 ÌáÈ¡Îļþ

[ Last edited by luai071 on 2007-10-30 at 18:10 ]
3Â¥2007-10-30 17:10:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)


´óС ÎļþÃû
21.7M  Papers--Bio.pdf

  
ÒѾ­³É¹¦µØ±£´æÔÚMofile  
ÎļþÌáÈ¡Â룺 0644639448462145
  
    µ±ÄúµÄÅóÓÑÐèÒªÌáÈ¡´ËÎļþʱֻÐè:
     ÄäÃûÌáÈ¡ÎļþÁ¬½Ó http://pickup.mofile.com/0644639448462145  
     »òµÇ¼Mofile£¬Ê¹ÓÃÌáÈ¡Âë 0644639448462145 ÌáÈ¡Îļþ


4Â¥2007-10-30 17:22:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[½Ìʦ֮¼Ò] ת³¤Æ¸ÁË +4 ¼òµ¥»¯xn 2026-04-13 4/200 2026-04-14 08:27 by syl200707
[¿¼ÑÐ] 279Çóµ÷¼Á +11 ÕÅ·¬ÇѲ»³´µ° 2026-04-11 11/550 2026-04-13 22:25 by zhq0425
[¿¼ÑÐ] 368»¯Ñ§Çóµ÷¼Á +14 wwwwabcde 2026-04-07 15/750 2026-04-13 08:36 by lhj2009
[¿¼ÑÐ] 086000µ÷¼Á +6 Ê®Æßsa 2026-04-07 6/300 2026-04-12 11:05 by ´óÁ¦Ë®ÊÖÁ¦´óÎÞÇ
[¿¼ÑÐ] µçÆø×¨Ë¶320Çóµ÷¼Á +6 СÂé×Ó111 2026-04-10 6/300 2026-04-12 10:54 by lemon6009
[¿¼ÑÐ] 0854µ÷¼Á +12 ³¤¹­°Á 2026-04-09 13/650 2026-04-12 09:56 by ÄæË®³Ë·ç
[¿¼ÑÐ] 267Çóµ÷¼Á +8 ÔÙæҲҪ³Ô·¹°¡ 2026-04-09 8/400 2026-04-11 21:42 by cfdbai
[¿¼ÑÐ] ²ÄÁϹ¤³ÌÈÕÓÉúÇóµ÷¼Á +7 0856?µ÷¼Á 2026-04-10 7/350 2026-04-11 21:33 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 296Çóµ÷¼Á +8 Íô£¡£¿£¡ 2026-04-09 8/400 2026-04-11 21:02 by ÄæË®³Ë·ç
[¿¼ÑÐ] 086003µ÷¼ÁÇóÖú +21 ËÕß®Íò 2026-04-09 22/1100 2026-04-11 20:25 by dongdian1
[¿¼ÑÐ] µç×ÓÐÅÏ¢279Çóµ÷¼Á£¬ÓÐÊé¶Á¾ÍÐÐ +8 wwwooden 2026-04-08 11/550 2026-04-11 20:22 by cq2548
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ354·Ö +5 ÓêÉùÓàÉú 2026-04-11 6/300 2026-04-11 16:12 by ÓêÉùÓàÉú
[¿¼ÑÐ] 085410-273Çóµ÷¼Á +6 X1999 2026-04-10 6/300 2026-04-11 10:32 by Delta2012
[¿¼ÑÐ] 283Çóµ÷¼Á£¬¹¤¿Æ£¡ +12 ËÕ´òË®7777 2026-04-08 12/600 2026-04-11 10:28 by ÄæË®³Ë·ç
[¿¼ÑÐ] »¯Ñ§¹¤³ÌÓë¼¼Êõ324µ÷¼Á +23 Ëï³£»ª 2026-04-09 25/1250 2026-04-11 00:07 by ÆïÅ£¶Éº®½­
[¿¼ÑÐ] 287Çóµ÷¼Á +15 Fnhc 2026-04-07 21/1050 2026-04-10 19:09 by chemisry
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖпÆÔº105500רҵ×Ü·Ö315Çóµ÷¼Á +6 lallalh 2026-04-09 7/350 2026-04-09 17:51 by lallalh
[¿¼ÑÐ] 348Çóµ÷¼Á +3 candyyyi 2026-04-09 3/150 2026-04-09 17:20 by ¶ÎΰÑÞ
[¿¼ÑÐ] ²ÄÁϹ¤³Ì322 +18 ¹þ¹þ¹þºðºðºð¹þ 2026-04-07 19/950 2026-04-09 10:44 by cymywx
[¿¼ÑÐ] 0860004 Çóµ÷¼Á 309·Ö +6 Yin DY 2026-04-09 6/300 2026-04-09 10:19 by °¡Àî999
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û